Bank of America’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
ACM
BL
WANY
NPT
CPIG
Bank of America's RNXT Position: Q1 2026 in Review
Bank of America sold out of RenovoRx (RNXT) in Q1 2026, closing a stake of 306 shares — an estimated $257 sold.
Bank of America first reported a position in RNXT in Q3 2021 and held it in 13 quarters. The position peaked at $96K in Q2 2022. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.
- Bank of America reported no remaining RenovoRx position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 306 RenovoRx shares in Q1 2026, an estimated $257.
- Bank of America first reported a position in RenovoRx in Q3 2021 and held it in 13 quarters.
- Bank of America's RenovoRx position peaked at $96K in Q2 2022.
- 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.